Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-25-103544
Filing Date
2025-08-06
Accepted
2025-08-06 07:51:13
Documents
97
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q lnth-20250630.htm   iXBRL 10-Q 3216531
2 EX-10.1 lnth-ex10_1.htm EX-10.1 11169
3 EX-31.1 lnth-ex31_1.htm EX-31.1 18958
4 EX-31.2 lnth-ex31_2.htm EX-31.2 19241
5 EX-32.1 lnth-ex32_1.htm EX-32.1 19781
  Complete submission text file 0000950170-25-103544.txt   12945990

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT lnth-20250630.xsd EX-101.SCH 1435022
100 EXTRACTED XBRL INSTANCE DOCUMENT lnth-20250630_htm.xml XML 2678607
Mailing Address 331 TREBLE COVE ROAD NORTH BILLERICA MA 01862
Business Address 331 TREBLE COVE ROAD NORTH BILLERICA MA 01862 978 671-8001
Lantheus Holdings, Inc. (Filer) CIK: 0001521036 (see all company filings)

EIN.: 352318913 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36569 | Film No.: 251187511
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)